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Background: Rapid detection of carbapenemase-producing gram-negative bacilli (GNB) 
is required for optimal treatment of infected patients. We developed and assessed a new 
disk carbapenemase test (DCT).
Methods: Paper disks containing 0.3 mg of imipenem and bromothymol blue indicator 
were developed, and the performance of the DCT were evaluated by using 742 strains of 
GNB with or without carbapenemases.
Results: The paper disks were simple to prepare, and the dried disks were stable at -20°C 
and at 4°C. The DCT detected 212 of 215 strains (98.6% sensitivity with 95% confidence 
interval [CI] 96.0-99.5%) of GNB with known class A (KPC and Sme) and class B (NDM, 
IMP, VIM, and SIM) carbapenemases within 60 min, but failed to detect GES-5 carbapen-
emase. The DCT also detected all two Escherichia coli isolates with OXA-48, but failed to 
detect GNB with OXA-232, and other OXA carbapenemases. The DCT showed 100% 
specificity (95% CI, 99.2-100%) in the test of 448 imipenem-nonsusceptible, but car-
bapenemase genes not tested, clinical isolates of GNB.
Conclusions: The DCT is simple and can be easily performed, even in small laboratories, 
for the rapid detection of GNB with KPC, NDM and the majority of IMP, VIM, and SIM car-
bapenemases.
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INTRODUCTION  
Carbapenem-resistant gram-negative bacilli (GNB) have 
emerged and spread worldwide. Although carbapenem resis-
tance can be due to porin loss or enhanced drug efflux, ac-
quired carbapenem resistance due to carbapenemase produc-
tion is a more serious problem, because the resistance can be 
transferred horizontally, even to genetically unrelated species. 
The time-consuming modified Hodge test was the only test rec-
ommended by the CLSI for the phenotypic detection of KPC-
type carbapenemases [1]. In 2015, the rapid Carba NP test was 
added to the CLSI recommendations [2-4]. The Blue Carba test 
is a modification of the Carba NP test, which uses the pH indi-
cator bromothymol blue (BTB) and the less costly antibacterial 
Tienam 500 (Merck Sharp & Dohme, Kenilworth, NJ, USA) and 
eliminates the bacterial lysis procedure [5]. Both the Carba NP 
and Blue Carba tests require an adjustment of imipenem sub-
strate pH, and both tests are performed in liquid phase in mi-
crotiter plates or microtubes. Besides the widely used nitrocefin 
disk method for detection of various β-lactamases, a disk 
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method with benzylpenicillin and cephaloridine plus clavulanic 
acid substrates has been used briefly to detect extended-spec-
trum β-lactamases [6].
The aim of our present study was to develop a rapid and sim-
ple disk test, based on detection of the acid formed from hydro-
lysis of imipenem by the increasingly prevalent GNB that pro-
duce class A KPC-type and class B NDM-type carbapenemases 
as well as the already prevalent metallo-β-lactamases (MBLs).
METHODS
1. Bacterial strains and carbapenemase gene detection
To assess the performance of the Disk carbapenemase test 
(DCT), a total of 742 strains of GNB were used consisting of 287 
reference strains and clinical isolates with known carbapene-
mases, and 448 imipenem-non-susceptible, but carbapenemase 
gene not tested isolates. PCR detection of carbapenemase genes 
was performed by using primers and test conditions as de-
scribed previously: blaKPC-2-like and blaGES-5 [7], blaNDM-1-like [8], 
blaIMP-1-like, blaVIM-2-like, and blaSIM-1-like [9], blaOXA-23-like and bla-
OXA-51-like [10], and blaOXA-48-like [11].
2. Preparation of imipenem disks
Injectable imipenem (Prepenem; JW Pharmaceutical, Seoul, 
Korea), containing 530 mg of imipenem (0.462 of total weight), 
532 mg of cilastatin sodium, and 20 mg of sodium bicarbonate, 
were used to prepare the imipenem-incorporated substrate 
disks. Based on preliminary tests, disks containing 0.3 mg of 
imipenem were prepared by using a 15 mg of imipenem (32.46 
mg of Prepenem) per 1,000 µL solution. To the weighed amount 
of imipenem-cilastatin powder, a 12 mg/mL NaCl solution (80% 
of total solution volume) and a 2mM ZnSO4 (Sigma-Aldrich, St. 
Louis, MO, USA) solution (10% of total solution volume) were 
added, and the mixture was immersed in a 43°C water bath for 
about 5 min to allow the powder to dissolve. A 0.8% BTB 
(Yakuri Pure Chemical, Osaka, Japan) solution was prepared by 
dissolving 0.8 g of the powder in 30 mL of ethanol and adding 
70 mL of distilled water (DW). And then the solution (10% of to-
tal solution volume) was added to the imipenem and ZnSO4 so-
lution. The resulting solution was at pH 7.0 without adjustment. 
While held at 43°C, 20 µL aliquots of the imipenem solution 
were dispensed to 6-mm-diameter and 0.6-mm-thick empty 
paper disks (Toyo Roshi Kaisha, Tokyo, Japan). The disks on 
the bottom of plates were dried by placing them in a 35°C incu-
bator with mechanical air circulation for 1 hr. The top side of the 
disks retained a green color after drying. The disks were stored 
in airtight microfuge tubes without desiccant at both 4°C and 
-20°C and were stable for at least 6 months. The mean inhibi-
tion zone diameter for Pseudomonas aeruginosa ATCC 27853 
decreased only 2 mm from 35 mm, and the rapidity of the DCT 
for the four control strains with KPC-2, NDM-1, IMP-1, and 
VIM-2 remained similar (data not shown).
3. Disk carbapenemase testing
To determine carbapenemase production, the bacterial isolates 
were subcultured overnight on Mueller-Hinton agar (Asan Phar-
maceutical, Seoul, Korea), which were prepared by using dry 
product from Remel (Thermo Fisher Scientific, Waltham, MA, 
USA). Increasing the amount of growth transfer by colony 
sweeping resulted in a faster positive DCT. Therefore, to com-
pare the speed of positive reactions for different carbapene-
mases, a relatively constant amount of growth was transferred. 
The disk was placed green topside down on a confluent growth 
and pressed gently by using forceps. Then, the disk was imme-
diately lifted and laid green side up by touching with 20 µL of 
DW, which was dropped on the bottom of a Petri dish, making it 
easier to release the clinging disk from the forceps. A false-posi-
tive reaction resulted without the addition of DW. The plate lid 
was replaced to prevent drying, and the color change of the disk 
was observed at room temperature. The carbapenemase-nega-
tive control strains, P. aeruginosa and Acinetobacter baumannii, 
were used to aid in the reading of the reaction.
4. Inhibition tests
Inhibition of KPC enzyme activity was tested by using a 1,000 
µg/20 µL tazobactam (Sigma-Aldrich) solution in DW. As an in-
expensive alternative, a 4.5g piperacillin-tazobactam injection 
(Jeil Pharmaceutical) was used, which contained 4g of piper-
acillin, 500 mg of tazobactam, 2g of dextrose, 200 mg of so-
dium citrate, and 1 mg of EDTA disodium. Inhibition of MBL 
was tested by using a 60 mM EDTA solution. Inhibitor solutions 
in a 20-µL volume were dispensed into the bottom of a Petri 
plate along with the same volume of DW. A heavy lawn of the 
test organism was transferred to three DCT disks that were then 
individually placed on a 20-µL aliquot of DW and the two differ-
ent inhibitor solutions. The presence of significant inhibition of 
color development in a disk was considered positive.
RESULTS
Immediately after the transfer of colonies, the color of the DCT 
disks was typically green, but was a more alkaline greenish blue 
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with the Acinetobacter spp. A carbapenemase-positive reaction 
started with a greenish yellow color that progressed to yellow, 
and even to orange yellow (Fig. 1). 
The sensitivity of the DCT was determined by using reference 
strains and clinical isolates with known carbapenemases (Table 
1). Typically, KPC-producing isolates started to show a positive 
reaction immediately after transfer of the organism to the disk. 
All 35 Enterobacteriaceae isolates with molecular class A car-
bapenemase (34 isolates with KPC and one with Sme-1) 
showed positive reactions within 10 min (Table 1), whereas five 
GES-5-producing isolates did not show a positive result until 90 
min (data not shown). 
Fig. 1. Examples of disk carbapenemase tests (A) and inhibition tests (B) showing the color of the disks at indicated times. Isolates were (1) 
Acinetobacter junii (AJU) 13/6/R1783; (2) Acinetobacter baumannii (ABA) 11/6/R2498; (3) A. baumannii 03/9/T104; (4) Acinetobacter 
nosocomialis (ANO) 15/4/B6548; (5) Pseudomonas aeruginosa (PAE) 11/11/U1203; (6) P. aeruginosa 97/143; (7) P. aeruginosa 95/1/704; 
(8) A. baumannii 15/1694; (9) Escherichia coli (ECO) 12/2/P57; (10) E. coli KD-1251; (11) Klebsiella pneumoniae (KPN) M0801, and (12) 
E. coli 15/5/141. Positive reactions progressed from greenish yellow to yellow. All KPC- and NDM-producing isolates showed fast and strong 
reactions, and the color progressed to orange yellow. An A. baumannii isolate with VIM-2 (2), a P. aeruginosa isolate with VIM-1 (6), and an 
E. coli isolate with OXA-48 (12) showed slow and weak reactions. A. baumannii with OXA-23 (8) did not show a positive reaction within 60 
min. Panel B is an example of inhibition by 1,000 µg of TZ (or by 1,000 µg of TZ in PTZ) and 60 mM EDTA. 
Abbreviations: PTZ, piperacillin-tazobactam; TZ, tazobactam.
 (1) (2) (3) (4)
 AJU ABA ABA ANO
 IMP-1 VIM-2 SIM-1 NDM-1
Inhibitors
 None TZ PTZ EDTA
 KPC-2                   1,000 µg  60mM 
 (5) (6) (7) (8)
 PAE PAE PAE ABA
 IMP-1 VIM-1 VIM-2 OXA-23
 (9) (10) (11) (12)
 ECO ECO KPN ECO
 VIM-2 NDM-5 KPC-2 OXA-48
Min
5
10
20
30
Min
5
10
20
Min
5
10
20
Min
5
10
20
Min
10
20
40
Min
5
10
15
20
Min
10
20
30
60
A B
(11) KPN 
(10) ECO          NDM-1
(9) ECO            VIM-2
(12) ECO            OXA-48
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Table 1. Sensitivity of the disk carbapenemase test as determined by assessing known carbapenemase-producing reference strains and 
clinical isolates
β-Lactamase Reference strains/isolates (N)
N of isolates positive at (min) N of positive/N of tested 
(%)≤5 6-10 11-–20 21-30 41-50 51-60 Inconsistent
Class A
   KPC-2 Ref. Klebsiella pneumoniae (1) 1 1/1
   KPC-2 K. pneumoniae (6) 6 6/6
   KPC-2-like K. pneumoniae (25) 23 2 25/25
   KPC-2-like Escherichia coli (1) 1 1/1
   KPC-3  Ref. E. coli (1) 1 1/1
   Sme -1 Ref. Serratia marcescens (1) 1 1/1
Subtotal (35) 33 2 0 0 0 0 35/35 (100)
Class B
   NDM-1 K. pneumoniae (5) 5 5/5
Citrobacter freundii (1) 1 1/1
Enterobacter cloacae (1) 1 1/1
Klebsiella oxytoca (1) 1 1/1
   NDM-1-like K. pneumoniae (3) 3 3/3
Acinetobacter baumannii (3) 2 1* 3/3
Acinetobacter grimontii (1) 1 1/1
Acinetobacter spp.(6)† 6 6/6
Subtotal (21) 19 1 1 0 0 0 21/21 (100)
   IMP-1 Ref. P. aeruginosa (1) 1 1/1
   IMP-6 P. aeruginosa (6) 3 3 6/6
   IMP-7 Ref. P. aeruginosa (1) 60 min+to Neg 0/1
   IMP-1-like P. aeruginosa (51) 42 9 51/51
   IMP-1-like Pseudomonas putida (1) 1 1/1
   IMP-1 A. baumannii (1) 1 1/1
   IMP-4 Ref. A. baumannii (1) 1 1/1
   IMP-1-like A. baumannii (8) 6 2 8/8
   IMP-1-like Acinetobacter junii (3) 3 3/3
   IMP-1-like Acinetobacter lwoffii (1) 1 1/1
   VIM-1 Ref. P. aeruginosa (1) 40 min+to Neg 0/1
   VIM-3 Ref. P. aeruginosa (1) 50 min+to Neg 0/1
   VIM-2 Ref. P. aeruginosa (3) 2 1 3/3
   VIM-2-like P. aeruginosa (16) 5 4 5 2 16/16
   VIM-2-like P. putida (47) 5 16 16 7 1 2‡ 47/47
   VIM-2-like A. baumannii (4) 3 1 4/4
   VIM-2-like A. junii (5) 3 1 1 5/5
   VIM-2-like A. lwoffii (1) 1 1/1
   VIM-2-like Acinetobacter spp. (2) 2 2/2
   SIM-1 Acinetobacter pittii (1) 1 1/1
   SIM-1-like A. baumannii (3) 1 1 1 3/3
   SIM-1-like A. lwoffii (1) 1 1/1
Subtotal (159) 75 44 24 10 1 2 156/159
Total (215) 127 47 25 10 1 2 212/215 (98.6)
Class D
   OXA-48 E. coli (2) 2 2/2
   OXA-232 E. coli (8) 0/8
   OXA-232 K. pneumoniae (13) 0/13
Total (23) 0 2 0 0 0 0 2/23 (8.7)
   OXA-23 Ref. A. baumannii (3) 0/3
   OXA-23-like A. baumannii (41) 0/41
   OXA-25, -26, -27 Ref. A. baumannii (3) 0/3
   ISAba1-OXA-51 A. baumannii (2) 0/2
Total (49) 0 0 0 0 0 0 0/49 (0)
*Positive in 15 min; †One isolate each of A. bereziniae, A. guillouiae, A. johnsonii, A. nosocomialis, A. soli, and A. pittii; ‡Positive at 10-60 min depending on 
repeat tests.  
Symbol and abbreviations: +, positive; DCT, disk carbapenemase test; Neg, negative; Ref., reference strain. 
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All 21 NDM-producing Enterobacteriaceae and Acinetobacter 
spp. isolates showed positive results within 15 min. Seventy-
three of 74 IMP-type MBL-producing Pseudomonas spp. and 
Acinetobacter spp. showed a positive reaction within 10 min. 
But one reference isolate with IMP-7 showed unreliable results: 
a positive reaction at 60 min or negative results in repeat tests 
(Table 1). 
The positive reaction of VIM-2-like MBL-producing Pseudo-
monas spp., especially P. putida, was slower than that of the 
IMP-1-like MBL-producing isolates. Seventy-eight of 80 isolates 
showed a positive reaction in ≤50-60 min. The remaining two 
strains, the VIM-1- and VIM-3-producing reference P. aerugi-
nosa, showed slow positive or negative reactions depending on 
repeat tests. Five SIM-1-like enzyme-producing isolates of Aci-
netobacter spp. showed positive reactions within 20 min. The 
DCT showed an overall sensitivity of 98.6% (212 of 215 isolates, 
95% confidence interval [CI]: 96.0-99.5%) in the detection of 
acquired MBLs and class A carbapenemases (Table 1). 
Only two Escherichia coli isolates with OXA-48 were DCT posi-
tive within 10 min, whereas the remaining 21 E. coli and Klebsi-
ella pneumoniae isolates with OXA-232 were DCT negative. 
None of the 49 A. baumannii isolates, including the 44 with an 
OXA-23-like gene, were DCT positive (Table 1).
Repeat tests showed that inherent MBL producers, one iso-
late each of Stenotrophomonas maltophilia with L1 and Pseudo-
monas otitidis with POM-1, showed slow positive reactions 
within 80-90 min and 11-20 min, respectively (data not shown). 
To determine the DCT specificity, imipenem-non-susceptible, 
but carbapenemase genes not tested isolates were used. 
Among the 36 isolates collected in 2011, 14 and six Pseudomo-
nas spp. and Acinetobacter spp. isolates, respectively, were 
DCT positive. Subsequently, MBL genes were detected in all of 
them (Table 2). In routine testing in 2015, 10 of 231 consecu-
tive P. aeruginosa isolates were DCT positive and blaIMP-1-like or 
blaVIM-2-like genes were detected in all of them, indicating 100% 
specificity (95% CI: 99.2-100.0%) for the DCT (Table 2). How-
ever, none of the 181 imipenem-non-susceptible Acinetobacter 
isolates in 2015 were DCT positive. Among these isolates, both 
blaOXA-51-like and blaOXA-23-like alleles were detected in all of the 
51 randomly selected isolates, indicating that a majority of the 
current imipenem-non-susceptible Acinetobacter spp. isolates 
in our institute are OXA-23-like enzyme-producing A. bauman-
nii (data not shown). 
Inhibition tests with 1,000 µg of tazobactam (using piperacil-
lin-tazobactam) and 20 µL of 60 mM EDTA per disk showed 
that for all 18 K. pneumoniae isolates with KPC-type enzymes 
and 11 Enterobacteriaceae and one Acinetobacter guillouiae 
isolates with NDM-type enzymes, the test interpretation was 
possible within 2-10 min depending on the isolate (data not 
shown). In a few isolates with the KPC enzyme, only partial inhi-
bition by tazobactam was observed, necessitating a comparison 
of disk color with those without the inhibitor. A majority of the 
isolates with NDM enzymes showed complete EDTA inhibition 
(Fig. 1B). EDTA inhibition was detected within 5-20 min in one 
E. coli strain with a VIM-2-like enzyme, and one each of Aci-
netobacter junii and P. aeruginosa with an IMP-1-like enzyme, 
and one P. aeruginosa with a VIM-2-like enzyme; however, the 
test required 15-60 min of observation time for seven P. putida 
isolates with VIM-2-like enzymes.
DISCUSSION
In the preliminary test, the DCT-positive reaction was more dis-
tinct with BTB (transition range pH 6.0-7.6) than with bromo-
cresol purple (transition range pH 5.2-6.8), and cell lysis using 
Bacterial Protein Extraction Reagent (B-PER; Thermo Scientific, 
Table 2. Specificity of the disk carbapenemase test as determined by testing imipenem-nonsusceptible, but carbapenemase genes not 
tested isolates
Year of isolation Organism (N of isolates) N of DCT positive 
N (%) of isolates with the carbapenemase gene:
blaIMP-1-like blaVIM-2-like blaSIM-1 blaNDM-1-like Total
2011 Pseudomonas aeruginosa (18) 10 9 1 0 0 10
P. putida (4) 4 0 4 0 0 4
Acinetobacter spp. (14) 6 2 2 1 1 6
2015 P. aeruginosa  (231) 10 8 2 0 0 10
Acinetobacter spp. (181)* 0 0 0 0 0 0
Total (448) 30 19 9 1 1 30 (100%)
*PCR showed that all 51 tested isolates had intrinsic blaOXA-51-like and blaOXA-23-like alleles.
Abbreviation: DCT, disk carbapenemase test.
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Pierce Biotechnology, Rockford, IL, USA) did not enhance the 
reaction (data not shown).
Without adjustment, 1,000 µL of solutions with imipenem 10 
mg (21.64 mg of Prepenem for 0.2 mg/disk), 15 mg (32.46 mg 
of Prepenem for 0.3 mg/disk), and 20 mg (43.29 mg of Prepe-
nem for 0.4 mg/disk), showed pH values of 6.8, 7.0, and 7.1, 
respectively. We decided to use 0.3 mg imipenem disks for this 
study because the 0.2 mg disks showed a faster positive reac-
tion but the colors faded more rapidly, whereas the 0.4 mg disks 
showed a slower positive reaction. In our study, all five GES-
5-producing isolates did not show a positive result until 90 min 
(data not shown). It was reported that all four GES-5-positive 
isolates were Carba NP test negative [12]. 
Only one each of Pseudomonas strains with IMP-7, VIM-1, 
and VIM-3 were available for testing, and they showed inconsis-
tent DCT results (Table 1). The results of the VIM-1-producing 
strain may be due to its 3-fold lower catalytic efficiency com-
pared with the VIM-2-producing strain [13]. Whether this slow 
reaction is typical of IMP-7, VIM-1, and VIM-3 remains ques-
tionable and requires further study. Two P. putida isolates with 
VIM-2-like MBLs showed positive reactions in 10-60 min de-
pending on the repeat tests. The minimum inhibitory concentra-
tion of imipenem for all these five strains with slow DCT reac-
tions was >32 µg/mL, suggesting that the slow positive reaction 
was not associated with the low level of resistance (data not 
shown).
The slightly faster positive reaction of Acinetobacter spp. with 
the VIM-2-like MBL (≤5 -30 min) compared with Pseudomonas 
spp. (≤5-50 min) with the same enzyme type may have been 
influenced by the larger amount of the usually thicker and non-
sticky growth of Acinetobacter spp. 
It was reported that all 24 isolates with OXA-48 and three with 
OXA-181 were Carba NP test positive [2]. Only two E. coli iso-
lates with OXA-48 were DCT positive within 10 min, whereas the 
remaining 21 E. coli and K. pneumoniae isolates with OXA-232 
were test negative, suggesting that the positive DCT is related to 
the higher imipenem catalytic activity (kcat/Km) of OXA-48 and 
OXA-181 than that of OXA-232 [14]. It was reported that A. 
baumannii isolates with OXA-23 and other OXA-type carbapen-
emases showed slow positive reactions to the Blue Carba test 
[5]. None of the 49 A. baumannii isolates studied, including 44 
with an OXA-23-like gene, were DCT positive (Table 1), possibly 
due to the lower catalytic activity [15]. 
In our study, in all of the 51 randomly selected imipenem-
non-susceptible isolates of Acinetobacter spp., both blaOXA-
51-like- and blaOXA-23-like alleles were detected, indicating that 
the majority of these isolates currently in our institute are OXA-
23-like enzyme-producing A. baumannii (data not shown). Like-
wise, all 46 carbapenem-resistant Acinetobacter spp. isolated 
from intensive care unit patients in China between 2012 and 
2013 were blaOXA-23-like gene-positive A. baumannii, and MBL 
genes were not detected in any of the isolates [16].
In routine laboratory practice, laboratories that perform disk 
diffusion susceptibility testing can apply the DCT for carbape-
nem-non-susceptible isolates by using growth on agar plates. 
For laboratories performing the broth microdilution method, col-
onies grown on primary blood agar plates can be tested by 
sweep transfer to the DCT disks. Reliable positive results can be 
obtained even when using culture plates kept at 4°C or at room 
temperature for a week. In fact, 2-day-old cultures tended to 
give more rapid positive reactions compared with cultures less 
than 24 hr of age (data not shown).    
A limitation of the present study is that only one VIM-1-pro-
ducing P. aeruginosa isolate was tested, and KPC-type car-
bapenemase-producing isolates were not present among the 
isolates tested for the DCT specificity. A second limitation is that 
all clinical isolates were only from Korea. 
In conclusion, the DCT can be easily performed, even in 
small laboratories, for the rapid detection of isolates with KPC-
type and NDM-type carbapenemases in addition to a majority of 
isolates with IMP-, VIM-, and SIM-type MBLs. The test is simple 
to perform, it does not require pH adjustment of the imipenem-
cilastatin solution for disk preparation, and the prepared dried 
disks are stable at both -20°C and 4°C. Cultures kept at 4°C or 
room temperature can also be used, and a cell lysis procedure 
is not required. Lastly, the color development of the disk is ob-
served at room temperature.
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